Industry
Medical - Devices
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 23, 2024 | 10:23 am
Portfolio Pulse from Vandana Singh
August 21, 2024 | 6:11 pm
Portfolio Pulse from Benzinga Insights
August 21, 2024 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
August 21, 2024 | 11:42 am
Portfolio Pulse from Benzinga Insights
August 20, 2024 | 7:45 pm
Portfolio Pulse from Benzinga Insights
August 07, 2024 | 9:30 pm
Portfolio Pulse from Benzinga Newsdesk
August 02, 2024 | 6:47 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 5:09 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 2:39 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.